Preclinical evaluation of [

Preclinical evaluation of [

Contrast media & molecular imaging (2016-08-26)

Christel Vangestel, David Thomae, Jeroen Van Soom, Johan Ides, Leonie Wyffels, Patrick Pauwels, Sigrid Stroobants, Pieter Van der Veken, Viktor Magdolen, Jurgen Joossens, Koen Augustyns, Steven Staelens

PMID27558262

RESUMEN

Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 are key players in cancer invasion and metastasis. Both uPA and PAI-1 have been described as prognostic biomarkers; however, non-invasive methods measuring uPA activity are lacking. We developed an indium-111 (

MATERIALES

Referencia del producto

Marca

Descripción del producto

RAB0555

Sigma-Aldrich

Human PLAU / Urokinase-type Plasminogen Activator ELISA Kit, for serum, plasma, cell culture supernatants and urine